Home / Inspections / 1232056

FDA Inspection 1232056 — LGM Pharma Solutions, LLC

LGM Pharma Solutions, LLC — FEI 3017140477

The FDA completed an inspection of LGM Pharma Solutions, LLC on January 24, 2025 in Irvine, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 24, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Irvine, CA (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)

Facility

Other inspections at this facility

  • 1230374 (VAI Fri Mar 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1120565 (NAI Fri Jan 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1062404 (VAI Fri Aug 17 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1006282 (NAI Mon Feb 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1007414 (VAI Tue Dec 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources